Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation

Transfusion
L C LaskyJ McCullough

Abstract

The management of hemotherapy in 31 cases of ABO- or Rh-incompatible bone marrow transplantation is described. Our experience confirms that ABO or Rh incompatibility does not adversely affect engraftment, patient survival, or incidence of graft-versus-host disease. Eighteen recipients with ABO antibodies against the donors' red cells (major incompatibility) were managed by different combinations of plasma exchange, transfusion of incompatible donor type red cells, and removal of donor-type red cells from the bone marrow before transplant. The only serious complication was delayed hemolysis in seven of nine patients who received incompatible red cell transfusions before transplant. Thirteen patients received bone marrow containing ABO antibodies against their red cells (minor incompatibility). Five were managed by centrifuging the bone marrow to remove plasma and reduce the amount of antibody. This did not cause substantial loss of stem cell activity (60-100% of original marrow), and no patients had complications related to the marrow transfusion. In contrast, two of seven patients who received uncentrifuged bone experienced hemolysis. Two of four Rh positive recipients who received marrow from an Rh negative donor developed ant...Continue Reading

Citations

Jan 1, 1993·Journal of Clinical Apheresis·B C McLeodH G Klein
Aug 1, 1987·Transfusion Medicine Reviews·L D Petz
May 1, 1984·British Journal of Haematology·W G HoR P Gale
Jun 1, 1991·Transplant International : Official Journal of the European Society for Organ Transplantation·R OrS Slavin
Mar 31, 2010·Journal of Translational Medicine·David F Stroncek, Raj K Puri
Aug 1, 1992·Annals of Hematology·P PihlstedtO Ringdén
Jan 1, 1995·Critical Reviews in Clinical Laboratory Sciences·L J McCarthyE R Broun
Dec 1, 1991·The American Journal of the Medical Sciences·E A SahovicR K Stuart
Jun 19, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Bela BalintMiroljub Trkuljic
May 25, 2007·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·L BardiauxF Roubinet
Jan 1, 1985·Journal of Clinical Apheresis·I SniecinskiK G Blume
Jan 1, 1985·Journal of Clinical Apheresis·L Wood, P Jacobs
Aug 29, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Georg StussiJörg D Seebach
Aug 21, 2002·Hematology·G GandiniG Aprili
Nov 28, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Emma WatzMichael Uhlin
Feb 18, 2004·Journal of Korean Medical Science·Se Hoon ParkJe Hwan Lee
Jul 6, 2004·Bone Marrow Transplantation·R RaimondiUNKNOWN Gruppo Italiano Trapianto di Midolla Osseo
Jan 1, 1992·Journal of Hematotherapy·J ZingsemR Eckstein
Jul 20, 2002·Bone Marrow Transplantation·G StussiJ D Seebach
Feb 18, 2003·British Journal of Haematology·Je-Hwan LeeKyoo-Hyung Lee
Apr 15, 2000·Journal of Clinical Apheresis·K M Grima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.